PDS Biotechnology (PDSB) Accounts Payables (2014 - 2026)
PDS Biotechnology (PDSB) recorded Accounts Payables of $6.39 million in Q2 2026, up 42.2% from $4.5 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Accounts Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, PDS Biotechnology reported Accounts Payables of $3.57 million, up 112.2% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $1.68 million in FY2024 (-75.9%), $6.98 million in FY2023 (+472.7%), $1.22 million in FY2022 (-6.9%) and $1.31 million in FY2021 (-7.5%).
- The Q2 2026 figure is the highest quarterly Accounts Payables since Q4 2023.
- On a year-over-year basis, Accounts Payables rose in four of the last seven quarters, with growth averaging 41.0%.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 472.7% in Q4 2023, against a decline of 75.9% in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | 6.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.39 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 5.18 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 6.98 Mn |
| Sep 30, 2023 | 5.37 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 2.38 Mn |
API Access
PDS Biotechnology Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();